Related references
Note: Only part of the references are listed.Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic marker
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2020)
Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report
Takuya Furuta et al.
BRAIN TUMOR PATHOLOGY (2020)
Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes
Maria Lastowska et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions
Damian Stichel et al.
ACTA NEUROPATHOLOGICA (2019)
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
Annekathrin Reinhardt et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging
Melanie Pages et al.
BRAIN PATHOLOGY (2019)
Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
David Capper et al.
ACTA NEUROPATHOLOGICA (2018)
Central nervous system (CNS) neuroblastoma. A case-based update
Federico Bianchi et al.
CHILDS NERVOUS SYSTEM (2018)
Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients
Tojo James et al.
HUMAN MOLECULAR GENETICS (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial
Eugene I. Hwang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets
Felix Sahm et al.
ACTA NEUROPATHOLOGICA (2016)
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2016)
Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data
Konstantin Okonechnikov et al.
BIOINFORMATICS (2016)
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Dominik Sturm et al.
CELL (2016)
SOX10 Distinguishes Pilocytic and Pilomyxoid Astrocytomas From Ependymomas but Shows No Differences in Expression Level in Ependymomas From Infants Versus Older Children or Among Molecular Subgroups
B. K. Kleinschmidt-DeMasters et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)
Sox10-A Marker for Not Only Schwannian and Melanocytic Neoplasms But Also Myoepithelial Cell Tumors of Soft Tissue A Systematic Analysis of 5134 Tumors
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
Kristian W. Pajtler et al.
CANCER CELL (2015)
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy
Carsten Friedrich et al.
NEURO-ONCOLOGY (2013)
Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial
Birgitta Lannering et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
Expression of SOX9 and SOX10 in central neuroepithelial tumor
U. Kordes et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas
SI Bannykh et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Share Paper
